What are the symptoms of bladder cancer – and how is it treated?
Immunotherapy drug durvalumab, sold under the brand name Imfinzi, could help reduce the risk of bladder cancer progressing or ...
Cure Today13d
Cisplatin-Based Chemo Regimen May Improve Survival in Bladder Cancer
Chemotherapy regimen shows potential to improve survival and reduce need for surgery in patients with muscle-invasive bladder ...
‘Game changer’ immunotherapy drug could lead to increased survival rates for bladder cancer patients
Patients with advanced bladder cancer treated with an immunosuppressant drug were a third less likely to see the disease ...
Lung cancer drug already available on NHS could cut bladder deaths
A lung cancer drug already available on the NHS has been proven to cut bladder cancer deaths and reduce the risk of the ...
University of Sheffield6d
Survival rates for patients with operable bladder cancer significantly improved by immunotherapy before and after surgery
A major clinical trial, led by the University of Sheffield, has revealed survival rates for patients with operable bladder ...
Nature9d
Bladder cancer articles from across Nature Portfolio
SRC-mediated reprogramming of energy metabolism towards glycolysis and the pentose phosphate pathway contributes to cisplatin resistance in bladder cancer. A genomic and transcriptomic analysis of ...
pharmaphorum16d
Trial win sets up new use for Astellas, Seagen's Padcev in bladder cancer
The latest results come from cohort H of the EV-103 trial, which enrolled patients with muscle-invasive bladder cancer (MIBC), which is usually treated with a combination of cisplatin to reduce ...
MedPage Today1mon
Study Highlights Trimodality Bladder-Preserving Therapy as Possible Option for Certain Bladder Cancer Patients
followed by conventional radiation therapy to the bladder, delivering 61.2 Gy in 34 fractions (over about 7 weeks) combined with radiosensitizing chemotherapy that included either cisplatin or ...